William J Catalona Selected Research

William J Catalona Research Topics

Disease

116	Prostatic Neoplasms (Prostate Cancer) 01/2023 - 05/2002
59	Neoplasms (Cancer) 01/2022 - 06/2002
8	Margins of Excision 05/2010 - 10/2005
6	7 Hereditary Prostate Cancer 04/2016 - 03/2006
4	Neoplasm Metastasis (Metastasis) 01/2022 - 08/2009
3	Carcinoma (Carcinomatosis) 04/2006 - 07/2004
2	Hemospermia 06/2009 - 12/2004
2	Prostatic Intraepithelial Neoplasia 01/2007 - 03/2005
1	Genetic Risk Score 01/2022
1	Lower Urinary Tract Symptoms 06/2014
1	Skin Neoplasms (Skin Cancer) 12/2013
1	Urinary Tract Infections (Urinary Tract Infection) 10/2013
1	Bacteriuria 10/2013
1	Pain (Aches) 10/2013
1	Fever (Fevers) 10/2013
1	Prostatitis 04/2010
1	Contracture 12/2009
1	Lung Neoplasms (Lung Cancer) 02/2009
1	Uterine Cervical Neoplasms (Cancer of the Cervix) 02/2009
1	Inflammation (Inflammations) 01/2009
1	Weight Loss (Weight Reduction) 01/2007
1	Obesity 01/2007
1	Prostatic Hyperplasia (Benign Prostatic Hyperplasia) 04/2006
1	Breast Neoplasms (Breast Cancer) 01/2004
1	Lung Diseases (Lung Disease) 07/2003
1	Carcinogenesis 05/2003
1	familial Prostate cancer 12/2002

Drug/Important Bio-Agent (IBA)

86	Prostate-Specific Antigen (Semenogelase)IBA 01/2023 - 06/2002
16	Biomarkers (Surrogate Marker)IBA 01/2020 - 12/2003
5	AndrogensIBA 01/2022 - 07/2002
4	Indicators and Reagents (Reagents)IBA 01/2023 - 09/2002
3	DNA (Deoxyribonucleic Acid)IBA 01/2015 - 01/2004
2	Androgen Receptors (Androgen Receptor)IBA 01/2022 - 07/2002
2	Messenger RNA (mRNA)IBA 01/2020 - 01/2004
2	p38 Mitogen-Activated Protein KinasesIBA 10/2019 - 08/2009
2	GenisteinIBA 01/2019 - 08/2009
2	Genetic Markers (Genetic Marker)IBA 02/2016 - 01/2003
2	Peptide Hydrolases (Proteases)FDA Link 12/2013 - 09/2006
2	Anti-Bacterial Agents (Antibiotics)IBA 10/2013 - 01/2009
2	Enzyme Precursors (Zymogens)IBA 04/2010 - 06/2004
2	hepsinIBA 09/2006 - 01/2004
2	NucleotidesIBA 07/2003 - 05/2003
1	LipidsIBA 01/2022
1	Fatty Acid Synthases (Fatty Acid Synthase)IBA 01/2022
1	Transcription Factors (Transcription Factor)IBA 01/2022
1	Type 5 Cyclic Nucleotide PhosphodiesterasesIBA 01/2022
1	Hormones (Hormone)IBA 10/2019
1	EphB4 ReceptorIBA 10/2019
1	Adenosine Triphosphate (ATP)IBA 10/2019
1	HMGB1 Protein (HMG1)IBA 10/2019
1	CalreticulinIBA 10/2019
1	Vitamin D FDA LinkGeneric 04/2016
1	Retroelements (Retrotransposon)IBA 03/2016
1	MethyltransferasesIBA 01/2011
1	Oxidoreductases (Dehydrogenase)IBA 05/2010
1	Coenzyme A (CoA)IBA 05/2010
1	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 05/2010
1	Protein Isoforms (Isoforms)IBA 04/2010
1	Matrix Metalloproteinase 2 (Gelatinase A)IBA 08/2009
1	Proteins (Proteins, Gene)FDA Link 08/2009
1	Transforming Growth Factor beta (TGF-beta)IBA 05/2009
1	Transforming Growth Factor beta1 (TGF beta 1)IBA 05/2009
1	NF-kappa B (NF-kB)IBA 05/2009
1	VimentinIBA 05/2009
1	Keratin-18 (Keratin 18)IBA 05/2009
1	ORALIT (ORS)IBA 02/2009
1	Kallikreins (Kallikrein)IBA 11/2007
1	podocalyxinIBA 03/2006
1	antineoplaston A10 (A 10)IBA 07/2004
1	Membrane Proteins (Integral Membrane Proteins)IBA 01/2004
1	MutL Protein Homolog 1IBA 01/2004
1	Caveolin 2IBA 01/2004
1	LuciferasesIBA 07/2003
1	Codon (Codons)IBA 05/2003
1	Calcitriol Receptors (Calcitriol Receptor)IBA 05/2003
1	Ribonucleases (Ribonuclease)IBA 12/2002
1	ElementsIBA 07/2002

Therapy/Procedure

55	Prostatectomy (Retropubic Prostatectomy) 01/2022 - 05/2002
14	Radiotherapy 06/2011 - 07/2005
9	Therapeutics 10/2019 - 08/2006
2	Conservative Treatment 01/2022 - 02/2016
2	Aftercare (After-Treatment) 04/2008 - 04/2007
1	Lasers (Laser) 01/2020
1	Castration 10/2019
1	Catheters 10/2013
1	Adjuvant Radiotherapy 11/2006
1	Brachytherapy 10/2006